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Reactive gliosis involving activation and proliferation of astrocytes and microglia, is a
widespread but largely complex and graded glial response to brain injury. Astroglial
population has a previously underestimated high heterogeneity with cells differing in
their morphology, gene expression profile, and response to injury. Here, we identified
a subset of reactive astrocytes isolated from brain focal ischemic lesions that show
several atypical characteristics. Ischemia-derived astrocytes (IDAs) were isolated from
early ischemic penumbra and core. IDA did not originate from myeloid precursors, but
rather from pre-existing local progenitors. Isolated IDA markedly differ from primary
astrocytes, as they proliferate in vitro with high cell division rate, show increased
migratory ability, have reduced replicative senescence and grow in the presence of
macrophages within the limits imposed by the glial scar. Remarkably, IDA produce a
conditioned medium that strongly induced activation on quiescent primary astrocytes
and potentiated the neuronal death triggered by oxygen-glucose deprivation. When
re-implanted into normal rat brains, eGFP-IDA migrated around the injection site and
induced focal reactive gliosis. Inhibition of gamma secretases or culture on quiescent
primary astrocytes monolayers facilitated IDA differentiation to astrocytes. We propose
that IDA represent an undifferentiated, pro-inflammatory, highly replicative and migratory
astroglial subtype emerging from the ischemic microenvironment that may contribute to
the expansion of reactive gliosis.
Main Points:
Ischemia-derived astrocytes (IDA) were isolated from brain ischemic tissue
IDA show reduced replicative senescence, increased cell division and spontaneous
migration
IDA potentiate death of oxygen-glucose deprived cortical neurons
IDA propagate reactive gliosis on quiescent astrocytes in vitro and in vivo
Inhibition of gamma secretases facilitates IDA differentiation to astrocytes
Keywords: reactive gliosis, inflammation, ischemia
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INTRODUCTION
Reactive gliosis is a widespread, however, largely complex
phenomenon and its biological role in the induction of neuronal
survival or death is still under debate. This is not an on/off
mechanism, but rather a graded process from a quiescent
state where astrocytes have individual territorial domains to
a hypertrophied state with overlapping domains and loss of
tissue architecture, ultimately leading to the formation of the
glial scar (Burda and Sofroniew, 2014). In addition to the
complexity of reactive gliosis as a process, astroglial population
has a -previously underestimated- high heterogeneity with cells
differing in their morphology, gene expression profile and
response to injury (Zhang and Barres, 2010; Wanner et al., 2013;
Parmigiani et al., 2015).
Studies on clinical and experimental focal ischemic lesions
have shown that brain ischemia invariably produces an ischemic
core and a surrounding area of penumbra. The core is a
region where all cell types die by necrosis due to the severely
limited blood supply in a short period of time, after an
episode of acute ischemia. In the hours following ischemia,
resident microglia become activated and the core is rapidly
invaded by blood-borne immune cells, being neutrophils the
first myeloid cell type initially found, followed thereafter
by infiltrating monocytes (reviewed in Benakis et al., 2015).
The ischemic penumbra surrounding the core is a region
where the blood supply was not completely restricted. It
remains electrically silent; neurons from this region will die
during the next 3–5 days. Penumbral astrocytes become
hypertrophied; they change their stellated morphology into
a polarized fibrillar reactive phenotype. Days later, reactive
astrocytes reorient their processes into a dense mesh that
forms a wall-like structure described as the glial scar (Silver
and Miller, 2004). Astrocyte scar formation is essentially
complete 2–4 weeks after acute insults (Burda and Sofroniew,
2014).
In recent years, it has been clarified that glial response to
acute ischemia involves the close interaction of resident glia
with the peripheral immune cells (Benakis et al., 2015). Blood
brain barrier (BBB) breakdown, chemotactic factors released by
activated microglia and damage associated molecular pattern
(DAMP) proteins release by necrotic cells, cause the recruitment
of professional immune cells from the periphery to invade the
ischemic region. It is still not clear how astrocytes interact with
invading leukocytes, but in vitro experimentation has shown that
astrocytes rapidly retract from the leucocytes-invaded area and
form scar-like structures (Wanner et al., 2008, 2013; Cregg et al.,
2014).
Evidence of the heterogeinity of astroglial cell population
has already been reported. For example, an atypical type of
astrocyte named aberrant astrocyte (AbA) has been purified
from primary spinal cord cultures of symptomatic transgenic
rats expressing the SOD1G93A mutation that leads to ALS-like
pathology in rodents (Díaz-Amarilla et al., 2011). These AbA
cells have a marked proliferative capacity, lack of replicative
senescence, secrete soluble factors that induce motor neuron
death and seem to derive from a microglia-astroglia phenotypic
transition (Trias et al., 2013). It has been also reported that
NG2-positive oligodendrocyte precursors (NG2-OPC) migrate
toward injury sites (Hughes et al., 2013) and NG2-expressing
microglia has been isolated from stab-injury lesions in wild
type adult rats (Yokoyama et al., 2006). While typical NG2-
OPC can give rise to oligodendrocyte as shown by lineage
tracing through in vivo imaging (Hughes et al., 2013); NG2
microglia can be turned into a multipotent phenotype by
exposure to 70% fetal calf serum (FCS) in vitro (Yokoyama
et al., 2006). In addition, the formation of neurospheres from
ischemic tissue in presence of EGF and FGF has been reported
(Shimada et al., 2012). Taken together, all these findings indicate
that undifferentiated and/or multipotent local astroglial cell
precursors emerge or are expanded in CNS lesions, however, until
now their amplification requires extensive genetic or chemical
manipulation.
Based on the reported evidence of astroglial heterogeneity
in different models of injury, we have here attempted the ex
vivo isolation of reactive astrocytes from focal ischemic tissue
obtained from the rat cerebral cortex, with the aim of finding
a sub-population of astrocytes with the ability to propagate
reactive gliosis. Taking into account that brain ischemia affects
the integrity of the BBB and induce brain cytokines production
that create a permissive environment for the recruitment of bone-
marrow derived immune cells (Mildner et al., 2007; Benakis
et al., 2015), we also investigated whether these astroglial sub-
population could be originated from myeloid precursors. Our
results show that ischemia-derived astrocytes (IDAs) obtained
from early ischemic lesions exhibit atypical phenotypic features,
including low replicative senescence, increased cell division and
migratory rates, with the potential to induce reactive gliosis on
quiescent astrocytes and neurodegeneration on oxygen-glucose
deprived neurons. Presumably, the atypical phenotype of these
IDA persists due to the presence of local signals that include the
activation of Notch1 pathway.
MATERIALS AND METHODS
Materials
Cell culture reagents were obtained from Invitrogen Life
Technologies (Carlsbad, CA, USA). Fetal calf serum (FCS) was
purchased from Natocor (Córdoba, Argentina). Antibodies were
purchased from Chemicon-Millipore (monoclonal anti-RAGE
cat# MAB5328; anti-actin cat# MAB1501; anti-NG2 Chondroitin
Sulfate Proteoglycan cat# MAB5384); Sigma [monoclonal
anti-S100B cat# S2532; polyclonal anti-S100T cat# S2644;
monoclonal anti-vimentin cat# V6630; monoclonal anti-glial
fibrillary acidic protein (GFAP) cat# G3893; monoclonal
anti-Bromodeoxiuridine (5-bromo-2′-deoxyuridine, BrdU)] cat#
B8434, Iowa University Hybridoma Bank (monoclonal anti-
nestin cat# rat-401) and Dako (polyclonal anti-GFAP Z0334).
Bromodeoxyuridine (BrdU), poly-L-lysine, DAPT (N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester); LPS
from Escherichia coli O55:B55 and other chemicals were
from Sigma. Fluorescent secondary antibodies and peroxidase
conjugated secondary antibodies were purchased from Jackson
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Immunoresearch. Images were taken in an Olympus IX-81
microscope equipped with a DP71 camera or Olympus FV-1000
confocal microscope (Olympus, Tokyo, Japan).
Cortical Devascularization
Adult male Wistar rats (300–350 g) were obtained from the
Animal Facility of the School of Pharmacy and Biochemistry,
University of Buenos Aires; the transgenic rat strain [Wistar-
TgN(CAG-GFP)184ys] (Mothe et al., 2005) was kindly provided
by Dr. Fernando Pitossi (FIL, Buenos Aires, Argentina). Animals
were housed in a controlled environment (12/12-h light/dark
cycle, controlled humidity and temperature, free access to
standard laboratory rat food and water) under the permanent
supervision of a professional veterinarian. For all surgical
procedures animals were anesthetized with ketamine/xylazine
(90/10 mg/kg i.p.). Rats were subjected to a unilateral cortical
devascularization (CD) as previously described (Herrera and
Robertson, 1989; Villarreal et al., 2011) making every effort to
reduce the suffering and the number of animals used. Briefly,
rats were placed in a stereotaxic apparatus, and a small surface
of skull between the coronal suture and the bregma line was
removed to expose the underlying vasculature. A 27-gauge needle
was used to cut the overlying dura and tear it away from the
underlying pia. A sterile cotton swab was then used to tear
back the pia and to disrupt the pial blood vessels overlaying
the exposed cortex. Immediately, small sterile cotton pieces
embedded in sterile saline solution were laid on the cortical
surface until all bleeding ceased (usually less than 50 s). All cotton
pieces were removed and the incision in the overlying skin was
then closed using the temporal muscle and the attached fascia
to cover the lesion site. The animals were housed individually
to allow recovery after the surgery for 1, 3, 7, and 14 days.
Sham animals were prepared by removing the skull as indicated,
leaving the vasculature intact. During the surgery and the whole
awakening period, body temperature was maintained by means
of a heating pad. Rectal temperature was monitored to preclude
hypothermia and to maintain 37.5 ± 0.5◦C until animals awoke.
The animal care for this experimental protocol was in accordance
with the NIH guidelines for the Care and Use of Laboratory
Animals, the principles presented in the Guidelines for the
Use of Animals in Neuroscience Research by the Society for
Neuroscience, the ARRIVE guidelines, and was approved by the
CICUAL committee of the School of Medicine, University of
Buenos Aires.
Dissociated Cell Culture and Explants
from Adult Ischemic Tissue
At different recovery time points [1, 3, 7, or 14 days post-lesion
(DPL)], animals were deeply anesthetized with ketamine/xylazine
(90/10 mg/kg i.p.) and sacrificed by decapitation. Brains where
rapidly removed and placed in Dulbecco’s modified eagle
medium (DMEM) under sterile conditions. Meninges where
then carefully removed and a very small region of the cortex
containing the ischemic area (typically 2 mm × 2 mm × 2 mm)
was dissected and placed in fresh DMEM. A similar fragment
from an equivalent cortical area in the contralateral hemisphere,
or obtained from sham animals, was removed to be processed
as control. Immediately after dissection, cortical explants where
mechanically dissociated using scissors and forceps and placed
in 15 ml Falcon tubes. After removing the DMEM medium,
tissue fragments where digested with 0.25% trypsin for 30 min
at 37◦C. DMEM supplemented with 10% FCS was added to stop
digestion, followed by trituration through a Pasteur pipette until
tissue clamps where no longer visible. Dissociated tissue was then
centrifuged at 1000 RPM for 5 min, the supernatant was removed
and pelleted cells where resuspended in complete DMEM
containing 10% FCS, 2 mM L-glutamine, 100 µg/ml penicillin-
streptomycin. Cell suspension was immediately transferred to
culture poly-L-lysine coated dishes or multiwell plates for further
culture characterization and experiments.
For intracortical injection of atypical ischemic astrocytes,
adult rats of the transgenic strain [Wistar-TgN(CAG-GFP)184ys]
weighing 250–300 g were subjected to focal brain ischemia by the
CD method (see above). At 3 DPL, ischemic areas were dissected
and atypical astrocytes cultures were obtained as stated before.
After 20 DIV, confluent cultures were trypsinized, re-seeded in
10 cm diameter cell culture plates and cultured for additional
25 days to obtain a highly enriched atypical ischemic astrocytes
culture. Then, cells were dissociated by treatment with 0.05%
trypsin for 5 min at 37◦C, washed three times and resuspended in
DMEM. Transgenic eGFP-IDA were delivered in the right cortex
(bregma, +2 mm; lateral, −2.5 mm; ventral, −1 mm) of naïve
wild type Wistar rats with a Hamilton syringe. The volume of
injection was of 2 µl, infused over a 4 min period of time, with
the syringe left in place for another 2 min to minimize reflux.
Contralateral hemispheres received only DMEM.
In a different experimental setup we performed culture
explants from ischemic and control tissue. Brains were dissected
and cortical explants were obtained by cutting cortical ischemic
region into four slices of similar size with a sterile blade. Each
slice was immediately plated in poly-L-lysine coated dishes with
complete DMEM. Co-culture experiments of tissue explants on
primary astrocytes were done essentially in the same way, but
explants were seeded on top of confluent astrocytes monolayers
obtained from neonatal pups as described below (Villarreal et al.,
2014).
Astroglial Cell Culture
Brains from neonatal rat pups (3 days-old) were removed and
brain cortices were isolated following the procedure described
in Villarreal et al. (2014). When cells reached confluence (8–
10 days), they were subjected to shaking at 180 RPM for 24 h at
37◦C to detach microglia and oligodendrocytes. Then, cells were
washed with pre-warmed supplemented DMEM, incubated for
additional 24 h, trypsinized and re-seeded for the experimental
procedures in either 12 or 24 wells plates that were maintained
in 5% CO2 at 37◦C in supplemented DMEM. Cultures obtained
with this procedure showed more than 95% astrocytes with
positive GFAP staining.
Primary Cortical Neurons
The cortical neuronal cultures were prepared from embryonic
day (E) 16 Wistar rats according to Goslin et al. (1988)
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with minor modifications described in Villarreal et al. (2011).
Oxygen-glucose deprivation (OGD) exposure was performed
after 7 days in vitro (7 DIV) by extracting the culture medium,
replacing it with glucose-free Neurobasal previously saturated
for 20 min with a gas mixture composed of 0.1% O2, 5% CO2,
and 94.9% N2. Neurons were then incubated for 30 min in the
hypoxic chamber in the presence of the previously mentioned
gas mixture. Then, medium was removed and replaced with
Neurobasal supplemented with B27 equilibrated in normoxic
conditions.
Isolation and Injection of eGFP+ Bone
Marrow Mononuclear Cells (BMMCs)
Femurs and tibias from adult rats of the transgenic strain [Wistar-
TgN(CAG-GFP)184ys] weighing 300–400 g were dissected. The
ends of the bones were cut, and the bone marrow was extruded
with 4 ml of α MEM plus 10% FCS by using a needle and a
syringe. Aspirates were centrifuged through a density gradient
(Ficoll-Paque Plus; 1.077 g/ml), for 30 min at 1000 × g. The
supernatant and the interface were combined and centrifuged
10 min at 1000 × g as previously described (Usach et al.,
2011). Around 15 × 106 cells were obtained from each animal.
The bone marrow mononuclear cell (BMMC) fraction contains
mesenchymal stem cells, hematopoietic and non-hematopoietic
stem and precursor cells (Herzog et al., 2003; Goel et al., 2009).
A total of 15–20 × 106 cells were resuspended in 300 µL of
medium and applied through the sacra media artery using a 21G
hypodermic needle. A group of rats was injected saline solution
as a control.
Immunofluorescence
After 1, 3, 7, or 14 days post-lesion (DPL), animals were
deeply anesthetized with ketamine/xylazine (90/10 mg/kg, i.p.)
and perfused through the left ventricle as described (Aviles-
Reyes et al., 2010). Brains were cryoprotected, snap frozen
and coronal 50 µm thick brain sections were cut using a
cryostat. Free floating sections were kept in a cryoprotective
solution (30% glycerol, 20% ethylene glycol in 0.05 M phosphate
buffer) at −20◦C until use. Brain sections from control and
ischemic animals (1, 3, 7, and 14 DPL) were simultaneously
processed in the free floating state as previously described
(Aviles-Reyes et al., 2010; Angelo et al., 2014). Primary and
secondary antibodies were diluted in a solution with 3% normal
goat serum and 1% Triton X-100 in PBS. Isotypic specific
secondary antibodies labeled with Alexa 488 or 594 were used
and nuclear counterstaining was made with DAPI 0.1 µg/ml.
For cell cultures, fixed cells were washed three times with
cold PBS and permeabilized with 0.1% Triton X-100. The
procedure was then followed as stated for tissue sections, using
the indicated dilutions of the primary antibodies with the
exception that Triton X-100 was not included neither in the
blocking nor in the antibody solution. Epifluorescence images
were obtained in an Olympus IX-81 microscope equipped
with a DP71 camera (Olympus, Tokyo, Japan) or in a
Zeiss Axiophot (Carl Zeiss, Oberkochen, Germany) microscope
equipped with a digital camera (Olympus Q5). Confocal images
were taken in an Olympus FV-1000 confocal microscope and
Z-stack projections are shown unless stated otherwise in the
figure.
Proliferation Assay
For proliferation rates comparison between primary glia and
atypical ischemic astrocytes, BrdU 600 ng/ml was added to the
tissue culture medium and cells were fixed 24 h later. Cells where
then incubated in 0.5 N HCl in PBS during 30 min followed by
incubation in borate buffer 0.1 M for additional 5 min. After three
washes with PBS, BrdU incorporation was detected following the
immunofluorescence protocol with a specific antibody against
BrdU.
Wound Healing Assay
Primary astrocytes or atypical ischemic astrocytes were cultured
until confluence (7–10 days) as stated above. A scratch was
made with a sterile micropipette tip to create a cell-free area.
Then, medium was changed and after 24 or 48 h, cells were
fixed and stained with anti-GFAP and DAPI nuclear counter-
staining. Images were captured at different time points (0, 6, 24,
48 h).
Immunoblotting
Cultured astrocytes were homogenized in NP-40 lysis buffer
[10 mM Tris (pH 8.0), 150 mM NaCl, 1% Nonidet P-40,
10% glycerol], with a protease inhibitors cocktail (Sigma),
PMSF 1 mM and sodium vanadate 10 mM. Total protein
quantification was performed using the Lowry assay (Lowry
et al., 1951) and corroborated developing membranes with an
anti-actin antibody as loading control. Samples with equivalent
protein content were separated by SDS-polyacrylamide gel
electrophoresis and transferred to a nitrocellulose membrane
as previously described (Ramos et al., 2007). Developing of
peroxidase activity was performed using ECL substrate for
chemiluminescence (Pierce) and captured in X-Ray film in a dark
room.
Quantitative Studies and Statistical
Analysis
Changes in astroglial cell morphology, area covered by the
cells, cell division rate and colocalization index (Manders’
colocalization index; Nakamura et al., 2007) were evaluated by
using the NIH ImageJ software and plugins on cells or tissue
sections immunostained as stated in each figure legend. Each
in vitro experiment was repeated three times using duplicates
or triplicates in each experiment. Experiments involving animals
were performed independently three times, and each experiment
used at least three animals. Representative experiments and
photographs or gels are presented in the figures. The data was
analyzed for normal distribution and homogeneity of variances
and then subjected to the appropriate test (parametric or non-
parametric) as stated in each figure legend. The statistical
software package used was GraphPad Prism 5.0 (San Diego,
CA, USA) and statistical significance was assumed when
p< 0.05.
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RESULTS
Astrocytosis in Brain Ischemia Induced
by Cortical Devascularization (CD)
Unilateral CD induced a permanent cortical focal ischemia with
a clearly defined ischemic core and surrounding penumbra
(Figure 1A). At 3 days post-ischemic lesion (DPL), the ischemic
core was revealed as a GFAP-negative stained area surrounded
by intense nestin immunoreactivity (Figure 1A). By 7 DPL,
penumbral astrocytes surrounding the core showed the change in
the classical stellated non-polarized morphology toward a fibrillar
phenotype with projections directed to the core (Figure 1A).
After 14 DPL, astrocytes surrounding the area of the ischemic
core have completely lost the symmetrical stellated morphology
and reoriented their processes to form the dense mesh typical
of the glial scar (Figure 1A). High magnification confocal
images also show the extreme changes in the phenotype of
penumbral GFAP-immunoreactive astrocytes from 1 to 14 DPL
(Figure 1B). In Figure 1C confocal images of nestin/GFAP
immunolocalization show that nestin expression, practically
absent in the control non-ischemic hemisphere, peaks at 7
DPL in astrocytes, concomitantly with a reduction in GFAP
expression levels (Figure 1C). Colocalization analysis performed
irrespectively of the intensity of the staining, however, showed
that nestin expression is mainly related to the GFAP-expressing
astrocytes (Figure 1C). We conclude that focal brain ischemia
by CD induces reactive gliosis with profound changes in the
astroglial phenotype, including the expression of the immature
glial marker nestin.
Atypical Astrocytes are Present in
Ischemic Tissue
In view of the dramatic changes of the astroglial population
in the peri-infarct region, we then attempted to isolate the
different cell types. For that purpose, we first seeded cortical
tissue explants containing the ischemic lesion of 1, 3, or 7
DPL animals, and incubated them on tissue culture plates
as described in Section “Materials and Methods.” Soon after
platting, cells showing different morphologies escaped and
migrated away from the ischemic cortical explants, to a
much greater extent compared to explants obtained from
LPS-injected animals, sham animals or even isolated from
the contralateral non-ischemic cortex (Figure 2A). By using
ischemic cortical explants from the transgenic eGFP rat strain
[Wistar-TgN(CAG-GFP)184ys] and tracking them on a time-
lapse microscope, we again observed the profuse cell escape
from the ischemic explants (Figure 2B). Figure 2C shows
in detail the different cell phenotypes that escape from the
ischemic explants during the first days in culture. Initially, small
rounded cells with a macrophage/microglia phenotype, showing
Iba-1(+)/S100B(+) immunostaining, escape and coexist with
a few polygonal S100B(+)/Iba1(−) cells (Figure 2C). Then,
extending the time of culture to 3–7 DIV, Iba1(+) cells
decrease in number and are segregated from those S100B(+)
cells that resulted expanded and still show elongated polygonal
morphology (Figure 2C). After 7 DIV these elongated polygonal
S100B(+) cells increase their number dramatically, densely
covering the periphery of the tissue explants as well as
distal regions (Figure 2C). Quantitative analysis of the area
occupied by S100B-only cells showed the significant increase
from 1 to 7 DIV (Figure 2C). Low GFAP expression was
normally associated with the S100B-immunoreactive elongated
polygonal cells (Supplementary Figure S1A). We conclude that
an atypical glial cell type expressing S100B and low GFAP
levels spontaneously escapes from ischemic tissue explants and,
based on the immunocytochemical profile we named them
IDAs.
We have thus shown that IDA are present in ischemic
tissue and spontaneous migration occurs in the presence of
macrophages/microglia. Knowing that brain ischemia induces a
permissive environment for the engraftment of bone marrow-
derived myeloid precursors and AbAs obtained from primary
spinal cord cultures of symptomatic transgenic rats expressing
the SOD1G93A mutation were shown to derive from a microglial-
astroglial phenotypical transition (Trias et al., 2013), in the
following experiments we analyzed if IDA could derive from
myeloid precursors recruited to the ischemic core. For that
purpose, we isolated BMMC from the transgenic eGFP rat
strain [Wistar-TgN(CAG-GFP)184ys] and transferred them
into wild type Wistar rats that were immediately subjected
to ischemia by CD. After 3 DPL, cortical explants from
the ischemic area were obtained and cultured for 3 DIV.
A detailed observation of the cells escaping from explants
showed that eGFP positive cells presented a small rounded
morphology, and we could not observe eGFP positive IDA
(Figure 2D). To further confirm successful distribution of
eGFP transferred cells in the receptor animal, we evaluated
the presence of eGFP positive cells in blood smears and in
liver and brain sections. In all these three types of samples
we observed eGFP positive cells (Supplementary Figure S1B).
We conclude that IDA isolated in vitro do not derive from
bone marrow myeloid precursors recruited to the ischemic
tissue.
Isolation and Characterization of
Ischemia-Derived Astrocytes (IDAs)
After detecting IDA in the ischemic explants, we decided
to evaluate whether these cells can be expanded in vitro to
analyze their cell biology and to compare them with quiescent
primary astrocytes. For that purpose, we subjected the animals
to brain ischemia and, after 3, 7, or 14 DPL we isolated
the cortical ischemic area in the ipsilateral and contralateral
hemispheres or in sham animals. The dissociated tissue was
cultured to screen the cells yielded after 1 and 7 DIV. While
contralateral or sham explants rendered a very reduced number
of cells that did not survive in vitro, 3 DPL ischemic explants
showed a larger total cell number and reduced number of
the macrophage/microglia phenotype, with enrichment in IDA
(fusiform morphology; S100Bhigh/GFAPlow immunoreactivity),
when analyzed at 7 DIV (Supplementary Figure S2). A closer
observation of the progression of culture of cells obtained from
3 DPL animals initially showed small rounded cells and few
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FIGURE 1 | Continued
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FIGURE 1 | Continued
Focal brain ischemia by cortical devascularization induces nestin expression, GFAP overexpression and glial scar formation in rats. (A) Low
magnification images of nestin (red) and GFAP (green) expression at 1, 3, 7, and 14 DPL (DPL, days post-ischemic lesion). Nestin expression (red) is very low in
control and 1 DPL animals and dramatically increased at 3 and 7 DPL, being still present at 14 DPL, bar = 1000 µm. (B) Confocal high magnification images show
how the astroglial stellated resting phenotype slowly changes toward a reactive, fibrillar and intermingled morphology forming the glial scar by 14 DPL, bar = 30 µm.
(C) Confocal high magnification images of penumbral astrocytes showing nestin/GFAP colocalization. The initial low nestin immunostaining in the perivascular
structures and absence of glial nestin until 1 DPL is dramatically altered by 3 and 7 DPL, showing high nestin expression in penumbral astrocytes. Bar = 15 µm.
Quantitative studies performed on tissue sections showed significant changes in nestin cell area that peaked on 7 DPL, while Manders’ colocalization index showed
the overlapping expression of nestin and GFAP on the penumbral astrocytes. Because of its calculation, Manders’ overlap coefficient measures the proportion of the
signal (nestin) colocalizing with the other signal (GFAP) without taking into account the intensity of the signals. Values are represented as mean ± SEM and statistical
significance was confirmed with the non-parametric Kruskal–Wallis test and Dunn’s Multiple Comparison Test. ∗p < 0.05, ∗∗p < 0.01; ∗∗∗p < 0.001.
isolated fusiform cells at 1 DIV (Figure 3A). Extending the
culture to 3 and 6–7 DIV dramatically increased the abundance
of fusiform polygonal cells similar to IDA observed escaping
from ischemic tissue explants (Figure 3B). This latter cell type
rapidly propagated, forming islands of cells (3 DIV) that quickly
colonized the plate to become the predominant phenotype by 6–7
DIV (Figure 3B). Immunofluorescence studies showed that this
prevailing fusiform cell type was immunoreactive for S100B and
weakly positive for Iba-1, tomato lectin or GFAP (Figure 3B)
as were IDA obtained from the ischemic explants. Additional
studies showed that the initially weak tomato lectin staining at
7 DIV was further reduced by 21 DIV, showing stable S100B
and low GFAP immunoreactivity (Figure 3B). Extending the
time in culture beyond 21 DIV and even increasing the number
of passages did not alter significantly IDA morphology, which
persisted as polygonal fusiform cells with S100Bhigh/GFAPlow
immunoreactivity without significant changes in morphology or
growth (Figure 3B and Supplementary Figure S3). IDA rapidly
populate the entire plate, but we found that this process can
be speeded up by incubation with conditioned medium (CM)
from OGD-exposed neurons presumably containing DAMPs or
by IDA CM itself (Figure 3C). This fact, together with the
consideration that IDA were isolated from deeply damaged tissue
containing a myriad of cytokines and DAMPs, that collectively
can activate NF-κB pathway, pointed us to test the effect of
NF-κB blockage in IDA initial proliferation. Blockage of NF-
κB activity with BAY 117082 failed to significantly decrease
IDA abundance but rendered smaller cells (Figure 3C). We
conclude that IDA obtained from ischemic tissue can be amplified
in vitro, they show a stable phenotype and S100Bhigh/GFAPlow
immunoreactivity and that they have reduced replicative
senescence.
As mentioned above, IDA rapidly populate the cell culture
plates and can be propagated for several passages with a stable
phenotype. Thus, we decided to study IDA cell division rate
and to compare it with that of primary astrocytes obtained from
neonatal pups, since primary astrocytes cannot be obtained from
non-injured adult brain tissue. Studies were performed on IDA
cultured for 7 DIV derived from 3 DPL ischemic brains, and
BrdU incorporation was compared to that achieved by a primary
astroglial culture of a similar confluence. As predicted, IDA
showed an increased BrdU incorporation compared to primary
astrocytes (Figure 3D) and migrated faster in wound healing
scratch assays, rapidly closing the wound in 24 h while primary
astrocytes required 48–72 h for a similar effect (Figure 3E;
Villarreal et al., 2014). We conclude that IDA isolated from
ischemic brains are highly proliferative and have increased
migratory capacity in vitro.
IDA Secrete Soluble Factors that Induce
Reactive Astrogliosis and Neuronal Death
When CM from IDA was collected and applied to quiescent
primary astrocytes cultures, they showed an increased expression
of the cytoskeletal proteins vimentin and GFAP (Figure 4A),
and increased stellation (Figure 4C), both signs of reactive
gliosis in vitro. However, IDA CM did not increase primary
astrocyte cell division rate, as shown by BrdU incorporation
(Figure 4B). Having in mind that neurons can be dramatically
affected by soluble mediators secreted by astrocytes, we then
tested the IDA CM effects on primary cortical neurons. While
IDA CM had no significant effect on neuronal death of cortical
neurons in control conditions, it increased LDH release when
applied on OGD-exposed neurons, an in vitro manipulation
that mimics the ischemic environment faced by neurons in vivo
(Figure 4D).
To further test the ability of IDA to induce reactive gliosis
in vivo, we obtained IDA from the eGFP+ rat transgenic strain
[Wistar-TgN(CAG-GFP)184ys] subjected to CD ischemia (3
DPL) and, after 25 DIV, we injected the eGFP-IDA intracortically
in naïve rats. As shown in Figure 4E, IDA induced a focal
reactive gliosis in the injection site that was significantly
larger compared with the contralateral hemisphere injected with
vehicle (Figure 4). The injected eGFP-IDA migrated around the
injection site but persisting in the area (Figure 4F). All these facts
indicate that IDA can induce astroglial conversion to the reactive
phenotype in vitro and in vivo and facilitate neurodegeneration
of OGD-exposed neurons.
IDA and Their Interaction with the
In Vitro Glial Scar
The close observation of cells escaping from ischemic explants
showed that macrophage/microglial cells and IDA escape, but
that IDA rapidly propagate and colonize the area. These
observations imply that IDA are not repelled by macrophages as
was described for primary astrocytes (Wanner et al., 2008, 2013).
To further analyze the IDA characteristics, we incubated the 3
DPL ischemic explants dissected from ischemic cortical areas of
the eGFP+ transgenic rat on top of a confluent monolayer of
quiescent primary astrocytes, and then followed the co-culture
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FIGURE 2 | Continued
Ischemia-derived astrocytes (IDAs) are present in ischemic explants and proliferate in vitro. (A) Representative images of cortical explants obtained from 3
DPL ischemic lesions, contralateral hemisphere, LPS-injected animals (5 mg/kg, i.p.) or sham animals showing a large number of cells that spontaneously escape
from ischemic tissue. Only cells derived from ischemic explants successfully survive in vitro. Quantitative results show the total number of cells escaping from
ischemic explants in a 0.5 mm2 area sectioned from the microscopic field. Values are represented as mean ± SEM and statistical significance was confirmed with
ANOVA and Student Newman Keuls post-test (∗∗∗p < 0.001). (B) Time lapse images acquired every 12 h of the same 3 DPL cortical ischemic explants from eGFP
transgenic rat strain [Wistar-TgN(CAG-GFP)184ys] showing the rapid escape of cells from ischemic explants observed from 1 DIV (DIV, days in vitro) to 4 DIV. Insets
show the detail of different cell morphologies and the abundance of fusiform cells by 4 DIV. Morphology of cells escaping from ischemic explants are different after 1,
2, 3, or 4 DIV. Polygonal or fusiform IDA are the predominant cells after 3–4 DIV. (C) Immunocytochemistry images showing the Iba-1 and S100B expression in the
cells escaping from ischemic explants. From 1 to 7 DIV the intense Iba-1 expression is reduced and S100B expression increased. Quantitative results show the area
occupied by the S100B(+)/Iba-1(−) (S100B-only) expressing cells. Values are represented as mean ± SEM and statistical significance was confirmed with the
non-parametric Kruskal–Wallis test and Dunn’s Multiple Comparison Test (∗∗p < 0.01). (D) Different representative images of IDA escaping away from the 3 DPL
ischemic explants after 3 DIV. Rats have previously been injected with eGFP+ BMMC and then were subjected to ischemia by cortical devascularization. Note that
eGFP+ cells have not fusiform IDA phenotype. Bar = 15 µm.
by time-lapse microscopy to study the spontaneous interaction
between the cells. As shown in Figure 5A, 3 DPL ischemic
explants induced the retraction of primary astrocytes and the
formation of a dense mesh with a scar-like structure that corrals
cells escaping from the ischemic explants after 2 DIV of co-
culture (Figures 5A,B), in close correlation with the effect
observed with meningeal macrophages by Wanner et al. (2013).
A detailed observation evidenced that a higher density of escaped
ischemia-derived eGFP+ cells with the macrophage/microglial
phenotype appeared in the astrocyte-free areas limited by the glial
scar (Figures 5C,D). Figure 5E shows the macrophage/microglia
cells and IDA colocalized in the astrocytic-free areas. Extending
the co-culture time to 5 DIV showed that polygonal fusiform
IDA turned into a classical stellated astrocytic morphology with
increased GFAP expression, starting to colonize the area limited
by the in vitro formed glial scar (Figures 5F–H). We conclude
that IDA migrate, proliferate and differentiate in the areas
delimited by the in vitro glial scar, showing a largely different
response compared to primary astrocytes.
We then considered whether IDA could induce glial scar
formation per se. For that purpose we cultured eGFP-IDA
for very long term (25 DIV) and obtained an essentially
pure IDA population as defined by their S100Bhigh/GFAPlow
immunolabeling and polygonal fusiform cell morphology. These
IDA cultures were then dissociated and seeded on top of a
primary astroglial cultures to follow the evolution of the co-
culture after 3 and 7 days by tracking the changes in the eGFP+
cell population. We did not observe glial scar formation in vitro,
but indeed we noticed that eGFP-IDA differentiated in the culture
to the classical stellated astroglial phenotype (Figures 5I,I′)
without showing the expression of oligodendrocytic lineage
markers like O4 (data not shown). We conclude that IDA have
unique features that render them able to proliferate in the vicinity
of macrophages, colonize the cell-free areas produced by the
astroglial retraction and retain the ability of differentiating into
astrocytes, but do not induce glial scar formation.
Blockage of Gamma Secretases
Facilitates IDA Differentiation into
Astrocytes
Having observed that IDA seeded on top of a confluent primary
astrocyte monolayer differentiate into astrocytes, we wondered
which were the signals of the microenvironment that maintained
the IDA phenotype. As it has recently been reported, the Notch1
signaling pathway regulates reactive astrocyte proliferation after
ischemia (LeComte et al., 2015). We thus tested the effects of
Notch1 signaling blockage by the gamma secretase inhibitor
DAPT on the IDA cultures. With that aim, we cultured eGFP-
IDA for 7 DIV and then treated the culture with DAPT and
follow the morphological changes. As shown in Figure 6A, 48 h
treatment with DAPT induced a phenotypic change in the IDA
from the fusiform to a stellated phenotype and increased the
ratio of GFAP immunoreactive cells in the culture (Figure 6B).
On the other hand, blockage of NF-κB signaling dramatically
reduced IDA survival and differentiation to astrocytes (data not
shown). We conclude that gamma secretase activity is necessary
to maintain the IDA phenotype, probably due to the requirement
of a Notch1-dependent pathway.
DISCUSSION
Clinical observations have shown that, in the days following focal
brain ischemia, the initial discrete necrotic core can propagate
into the penumbra, thus worsening clinical prognosis. These
clinical findings are also supported by data from experimental
stroke models where neuronal death and reactive gliosis
originally present in the core and vicinity may slowly progress
toward the penumbra and adjacent healthy tissue, thus increasing
the secondary damage. After variable periods of time, a dense
mesh of intermingled fibrillar astrocytes known as the glial scar
surrounds and isolates the ischemic region that has been occupied
by fibromeningeal cells and blood derived myeloid immune
cells.
A long standing hypothesis in the field is that, beneath a
common immunocytochemical pattern and similar morphology,
astroglial population is heterogeneous and there might be several
masked reactive astrocytic phenotypes with different potential
and physiological roles, including their ability to facilitate
neuronal survival or death (Zhang and Barres, 2010; Anderson
et al., 2014). In previous reports, different populations have
been amplified by using extensive tissue culture manipulations
including high levels of serum or other trophic factors
(Yokoyama et al., 2006; Shimada et al., 2012; Götz et al.,
2015). Consistently, in this study we have found and identified
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FIGURE 3 | Ischemia-derived astrocyte can be isolated and amplified in vitro showing increased rate of cell division and migration. (A) Images of the
progress of the dissociated culture after 1, 3, and 6 DIV starting from ischemic cortex of 3 DPL animals, bar = 15 µm. (B) Representative images of 7 and 21 DIV
cultures of IDA stained with the macrophage/microglial marker tomato-lectin FITC (green) and the glial marker S100B (red). Note the reduction in the tomato-lectin
staining and the increase in S100B expression as the culture develops. Bar = 20 µm. (C) Representative images of low density IDA cultures (7 DIV) derived
from eGFP transgenic rats and incubated with conditioned medium (CM) of OGD-exposed neurons, CM of IDA primary culture (P0) or BAY 117082 50 µm. Quantitative
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 June 2016 | Volume 10 | Article 139
fncel-10-00139 May 30, 2016 Time: 15:14 # 11
Villarreal et al. Ischemia-Derived Astrocytes
FIGURE 3 | Continued
results showed the significantly increased IDA yield when the culture was exposed to CM derived from IDA or OGD-exposed neurons. Values are represented as
mean ± SEM (cell number per field) and statistical significance was confirmed with ANOVA and Student Newman Keuls post-test (∗∗∗p < 0.001; ∗∗p < 0.05).
(D) Quantitative analysis of BrdU incorporation after 24 h comparing an IDA culture with quiescent primary cultured astrocytes at the same confluence. Values are
represented as mean ± SEM (percentage of BrdU+ cells per field counterstained with nuclear DAPI) and statistical significance was confirmed with the
non-parametric Kruskal–Wallis test and Dunn’s Multiple Comparison Test (∗∗∗p < 0.001). (E) Representative images of IDA rapidly invading the artificial wound
performed on high density cell culture wounded with scratches, fixed at the indicated times and stained with S100B or vimentin (Vim). Comparative drawings and
quantitative analysis of the scratch width after 24 h post-scratch wound injury showing that IDA migrate significantly faster than primary cultured astrocytes.
Statistical significance was confirmed by Wilcoxon two tailed t-test (∗p < 0.05).
a subpopulation of astrocytes (IDA) that is induced in an
early time window following focal brain ischemia (3–7 days)
and, due to their increased migratory ability, spontaneously
escape from ischemic tissue explants in vitro. Moreover, IDA
can be isolated, maintained and amplified in vitro, have
increased migratory ability, high cell division rate, express
markers related to immature glial cell lineage and show reduced
replicative senescence compared to primary astrocytic cultures.
Interestingly, the CM obtained from IDA cultures induces
reactive gliosis when applied on quiescent primary glia and
facilitates neuronal death of OGD-exposed cortical neurons.
When IDA were reintroduced into non-ischemic brains, they
induced reactive gliosis in vivo. In addition, IDA rapidly
proliferate and differentiate to the astroglial lineage, occupying
the corral-like structures produced by the glial scar formation
in vitro. While IDA expansion is facilitated by CM from OGD-
stressed neurons or IDA cultures, the IDA phenotype is lost when
gamma secretases are blocked.
It has been reported in experimental spinal cord injury
lesions that focal injury induces the proliferation of reactive
astrocytes that are heterogeneous in phenotype in a manner
that varies with the distance from the lesion (Wanner et al.,
2013). We have found here that IDA can only be amplified
from tissue obtained from the ischemic core and penumbra
in a time window between 3 and 7 days after the ischemic
injury. Interestingly, it is not enough to induce a generalized
reactive gliosis with peripheral LPS administration, since IDA
were not obtained from the cortical explants of LPS-treated
animals. Neither were IDA obtained from the contralateral
hemisphere in animals subjected to unilateral ischemia by CD
nor in sham animals. In our experiments, nestin expression
in the focal ischemic area strongly correlates with the time
window for IDA migration and isolation. Nestin is expressed
by glial progenitors and also by reactive astrocytes induced by
brain ischemia, but it is not expressed after peripheral LPS
administration (Zamanian et al., 2012). We have found that
the peak of nestin expression after ischemia by CD occurs
between 3 and 7 DPL and IDA can only be isolated during
this time window. By 14 DPL, when the glial scar is formed,
IDA can no longer be obtained. Apparently, there is a time-
window after the ischemic lesion which provides a permissive
environment for IDA to proliferate and migrate. Furthermore,
IDA could not be obtained either at very early time points
such as 1 DPL, thus indicating that initial expansion of this
atypical glial cell population probably requires additional signals
beyond the acute lack of glucose and oxygen induced by brain
ischemia.
Ischemia-derived astrocytes localized in the ischemic tissue
spontaneously migrate away from the explants seeded in tissue
culture chambers. Escaped IDA seem not to be repelled by Iba-
1(+) macrophage/microglia. Again, this is an IDA unique feature
since it has been shown that primary astrocytes spontaneously
surround and segregate from macrophages and fibromeningeal
cells into separated cell clusters (Wanner et al., 2008, 2013). IDA
seem not to behave as primary astrocytes and can coexist in the
area intermingled with macrophages.
The stable expression of S100B and low GFAP levels are other
intriguing characteristics of IDA. In addition, in our hands IDA
do not express detectable levels of NG2 (data not shown). Indeed,
IDA are recovered from ischemic tissue before the time when
NG2 positive cells appear in focal lesions (Cregg et al., 2014).
When seeded on top of confluent primary astrocytic monolayers
or in presence of DAPT gamma secretase inhibitor, a known
blocker of Notch1 pathway (LeComte et al., 2015), IDA mainly
differentiate into stellated astrocytes expressing GFAP without
noticeable differentiation to oligodendrocytes, showing that they
are restricted to the astroglial lineage.
Cell division rates and migratory abilities of IDA after
in vitro isolation are remarkable. The IDA high proliferation
rate allows the rapid colonization of the tissue culture plates,
even starting from a highly diluted culture. We show here that
this process is facilitated by soluble mediators secreted by OGD
exposed neurons or by medium from the IDA culture itself,
thus evidencing a major role of soluble mediators from the
microenvironment in IDA expansion. Indeed, IDA also showed
reduced replicative senescence, permitting long term cultures
and several cell passages without substantial loss of cell viability
or change in the S100Bhigh/GFAPlow phenotype. Both the high
proliferation rate and lack of replicative senescence are shared
by the ALS AbAs described by Díaz-Amarilla et al. (2011) in
the lesions of SOD1G93A mice. On the other hand, IDA seem
to retain the ability to differentiate into mature astrocytes, thus
evidencing a partially more restrictive lineage when compared
to the cells forming the neurospheres obtained after ischemia by
Shimada et al. (2012). Rat primary microglia expressing NG2 can
give rise to neurospheres that originate neuroectodermal cells in a
two-step culture using 10 and 70% serum-supplemented medium
(Yokoyama et al., 2006). However, IDA do not seem to derive
from NG2 cells. Our experiments with eGFP-BMMC evidenced
that IDA isolated from ischemic brains are not derived from
immune myeloid precursors recruited to the ischemic injury site,
neither do they express NG2. Shimada et al. (2012) were able
to obtain neural spheres in cultures derived from the cortical
peri-infarct area that are supposed to be originated in reactive
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FIGURE 4 | Ischemia-derived astrocyte induce reactive gliosis and neuronal death. (A) Immunoblot showing the increase in GFAP and vimentin (Vim)
expression in primary cultured astrocytes incubated during 24 h with astrocytic control medium or CM of P0 (initial confluent cultures) or P1 (after one passage) IDA.
Actin was used as loading control. Values indicate the OD ratio of vimentin vs. actin. (B) Quantitative analysis of cell proliferation (BrdU incorporation) after 24 h of
incubation of primary astrocytes with IDA conditioned or control medium. The statistical significance was analyzed by Mann Whitney two tailed t-test.
(C) Representative images of astrocytic stellation induced by the exposure of primary quiescent astrocytes to the CM from IDA cultures. Note the change from the
astroglial resting polygonal phenotype to the reactive stellated morphology induced by the IDA CM, bar = 25 µm. Quantitative analysis of the abundance of polygonal
astrocytes (number of polygonal cells per 1000 µm2) in the culture treated with IDA CM. The statistical significance was analyzed by Student two tailed t-test
(∗p < 0.05). (D) Primary cortical neuronal death analyzed by the LDH release (mU/L) into the culture medium after 24 or 48 h exposure to CM obtained from primary
astrocytes or IDA. OGD exposure was performed during 30 min. Results were shown as mean ± SEM (∗p < 0.05 as indicated; aap < 0.01; aaap < 0.001 vs. similar
conditions in control neuronal culture after ANOVA and Student Newman Keuls post-test). (E) Low magnification confocal images showing the injection of eGFP-IDA
in an uninjured brain. GFAP staining showing astrocytes is depicted in red; contralateral hemisphere injected with vehicle is presented as control. The graph shows
the quantitative analysis of the area occupied by GFAP astrocytes in the IDA-injected hemisphere and the contralateral hemisphere. Statistical significance was
tested by two tailed Student’s t-test (∗∗p < 0.01). (F) Confocal image showing the interaction between injected IDA and resident astrocytes from the host animal.
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FIGURE 5 | Continued
Cells escaping from the ischemic explants induce glial scar formation in vitro, and IDA colonize the cell-free areas. (A,B) Brain cortical ischemic
explants (IE) obtained from eGFP+ animals subjected to ischemia after 3 DPL, seeded on primary astrocytic confluent monolayers during 3 DIV induced the
formation of glial scar-like structures (arrow) that clustered and segregated cells escaping from explants, as easily seen in bright field (A) and escaping eGFP+ cells
(B) observed under UV illumination, bar = 500 µm. (C,D) Representative images of cells escaping from ischemic explants showing that the majority of cells were
clustered in the astrocytic-free areas (C) compared with the area with astrocytes limited by the scar-like structure (arrow) (D). (E) High magnification detail of eGFP
cells escaping from ischemic explants showing the different phenotypes, going from macrophage-like rounded phenotype (thin arrow) to the polygonal fusiform IDA
(thick arrow). (F,G) IDA growing within the limits imposed by the corral glial scar-like structure by 5 days after seeding the eGFP+ ischemic explants on primary
astrocytic monolayers. The mesh-like in vitro scar is clearly seen when stained with GFAP (red; arrow). (H,H′,H′ ′) Images of eGFP-IDA differentiated to stellated
GFAP+ astrocytes in the vicinity of the astrocytic monolayer and scar-like structures stained with GFAP (red). (I) Several eGFP-IDA morphologically differentiated to
stellated astrocytes (I) when seeded on top of a confluent primary astrocytic monolayer that is visible under phase contrast (I′).
FIGURE 6 | Ischemia-derived astrocyte phenotype persistence requires gamma secretase activity. (A) Representative images of eGFP-IDA cell cultures of
7 DIV showing the phenotypical transformation from the fusiform morphology to the stellated morphology induced by the 48 h-treatment with the gamma secretase
inhibitor DAPT; control cells received vehicle; bar = 25 µm. (B) Relative abundance of GFAP immunostained astrocytes in the eGFP IDA cultures after treatment with
different DAPT concentrations. Statistical significance was confirmed with the non-parametric Kruskal–Wallis test and Dunn’s Multiple Comparison Test (∗p < 0.05).
astrocytes since they are tagged with GFAP-tdRFP. However,
these glial-derived neurospheres require EGF and FGF to be
developed and expanded in vitro, showing an striking contrast
with IDA, which spontaneously escape from ischemic tissue
explants, migrate and proliferate at a high division rate. The IDA
obtained by us from tissue explants proliferate in vitro in normal
astroglial culture medium as a monolayer without any added
trophic factor beyond the 10% classical level of FCS. Reactive
astrocytes are heterogeneous after injury as they differentially
express proteins associated with stem/progenitor cells (White
et al., 2010). We cannot rule out, however, that IDA could
be further de-differentiated and form neurospheres, given the
necessary specific supportive trophic factors. Since migration of
SVZ neuroblasts was not detected by 3 days after stroke (Shimada
et al., 2012), we propose that IDA are being generated from local
precursors activated by the permissive environment generated
by the ischemic injury. Another distinctive characteristic of IDA
is the ability to induce reactive gliosis on quiescent astrocytes
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in vitro and in vivo. Exposure to IDA CM also facilitates neuronal
death in OGD-exposed primary cortical neurons. Interestingly,
only neurons that have been exposed to OGD are significantly
sensitive to the IDA toxic effects, thus supporting the idea
that only stressed neurons can be killed by IDA. Both us and
others have reported that OGD induces the expression of Pattern
Recognition Receptors as RAGE, that are likely to be involved in
this astrocyte-mediated neuronal killing (Villarreal et al., 2011;
Kamide et al., 2012; Angelo et al., 2014). Furthermore, AbAs
in the ALS transgenic model showed the ability to specifically
induce motor neuronal death without affecting other neuronal
types (Díaz-Amarilla et al., 2011).
Glial scar formation is a key feature of focal CNS lesions. As
previously demonstrated by Wanner et al. (2008, 2013), primary
astrocytes actively surround macrophages and spontaneously
form scar-like structures that corral inflammatory meningeal
macrophages in a STAT-3 dependent manner. By using a similar
experimental paradigm, we incubated ischemic explants on top
of confluent primary astrocytes and observed that astrocytes
actively form corral structures surrounding the explants. IDA
migrate from the ischemic tissue explants occupying the corral
structure formed by primary astrocytes. It is clear that IDA
are not being repelled by macrophages and can proliferate
and differentiate in their presence. IDA are not able, however,
of forming scar-like structures in vitro or in vivo as shown
by the IDA-astrocytes co-culture and in vivo intracortical
cell transfer. In this scenario, a tempting hypothesis is that
IDA expansion and proliferation is the result of the presence
of soluble mediators from the ischemic tissue that activate
local resident astroglial cell precursors. Stabilization of the
IDA phenotype, however, seems to require gamma secretase
activity and thus Notch1 signaling is an obvious candidate
for that role. Based on the results obtained in the inducible
transgenic GFAP-CreER-Notch1-cKO and GFAPCreER-ETBR-
cKO mice, LeComte et al. (2015) determined that the Notch1–
STAT3–ETBR axis connects a signaling network that promotes
reactive astrocyte proliferation after brain ischemia. In this
scenario, it is tempting to speculate that IDA phenotype
stabilization requires Notch1 signaling, and thus the gamma
secretase inhibitor DAPT, that blocks Notch1 signaling, allows
IDA differentiation into GFAP-expressing astrocytes. However,
the fully testing of this pathway on IDA deserves further
experimentation.
In summary, this study reports the identification and isolation
of an atypical astrocyte sub-population, named IDA, induced
by brain ischemia and presumably localized in the ischemic
penumbra. The most striking characteristics of this cell type
include the facilitation of neuronal death of OGD-stressed
neurons and the induction of reactive gliosis on quiescent
astrocytes. In view of our results, we consider IDA to have a
key role in the pathophysiological features of brain ischemia,
specifically in the progression of reactive gliosis, neuronal death
and subsequent proliferation within the limits of the glial
scar, thus representing an interesting target for therapeutic
strategies.
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FIGURE S1 | (A) Most IDA escaping from ischemic explants express S100B and
only some of them are differentiated into stellated GFAP+ astrocytes after 7 DIV,
bar = 30 µM. (B) Representative images of eGFP+ cells found in blood smear,
liver and brain in the ischemic animals after 3 DPL. The insets show high
magnification images of eGFP+ cells present in these preparations.
FIGURE S2 | Cell recovery after ischemia. (A) Total number of cells recovered
at 1 or 7 DIV starting from ischemic cortex of 1, 3, or 7 DPL. (B) Percentage of
microglia/macrophage phenotype after 1 or 7 DIV starting from similar ischemic
cortical tissue of 1, 3, or 7 DPL. Values represent the mean ± SEM and statistical
significance of the effects was confirmed with ANOVA and Student Newman Keuls
post-test (∗p < 0.05; ∗∗p < 0.01).
FIGURE S3 | Images show the persistent stable polygonal fusiform
phenotype of IDA after none (P0), one (P1), or two (P2) passages,
bar = 15 µM.
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